Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

The Dark Report

Prognostic versus Diagnostic Lab Medicine

MOST OF YOU ARE FAMILIAR WITH THE RACE TO DEVELOP effective laboratory tests and pharmaceuticals based on rapidly-developing genetic and molecular knowledge. We all ask the same question: when will my laboratory have to buy this technology and offer these new tests? For most of us, the answer is “not soon.” There is lots of …

Prognostic versus Diagnostic Lab Medicine Read More »

To access this post, you must purchase The Dark Report.

Cheerios® Teaching Consumers Facts About Laboratory Testing

FOR YEARS, BOTH HOSPITAL LABS and independent commercial labs considered physicians and payers to be the primary customers for lab testing. The lab testing needs of patients as customers seldom came up when lab managers discussed how to organize and deliver their lab’s testing services. In fact, most labs limited themselves to producing an array …

Cheerios® Teaching Consumers Facts About Laboratory Testing Read More »

To access this post, you must purchase The Dark Report.

“November 13, 2000 Intelligence: Late Breaking Lab News”

Last Thursday was the day Dynacare, Inc. hoped to place its initial public offering. Dynacare seeks to raise as much as $89 million by selling its shares to the public. However, the unresolved presidential election on Tuesday caused turmoil on the stock market during the remainder of the week. As this issue of THE DARK REPORT …

“November 13, 2000 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

Medical Arts Lab Opts To File For Chapter 11 Bankruptcy

CEO SUMMARY: Dissident shareholders and a crushing debt burden are the reason Medical Arts Laboratory decided to file for reorganization under Chapter 11 bankruptcy laws. Both factors are the legacy of an ill-fated attempt to create a national laboratory organization between 1994 and 1997. It’s the story of a business strategy that brought Medical Arts …

Medical Arts Lab Opts To File For Chapter 11 Bankruptcy Read More »

To access this post, you must purchase The Dark Report.

AmeriPath & InformDX Merging To Form Largest Anatomic Pathology Firm in U.S.

CEO SUMMARY: AmeriPath and InformDX shared several common elements in their respective business strategies. Both companies believe that pathology services are best delivered at the local level and benefit from the support of a national organization. Both companies believe that physicians must play a major role in designing and delivering anatomic pathology (AP) services. But …

AmeriPath & InformDX Merging To Form Largest Anatomic Pathology Firm in U.S. Read More »

To access this post, you must purchase The Dark Report.

Beware What Your Lab Competitor is Doing!

TODAY I WOULD LIKE TO SPEAK SPECIFICALLY to hospital lab administrators and owners of independent commercial laboratories. I would like to offer some friendly counsel: it’s time to pay careful attention to the most successful of your laboratory competitors. Undeniable evidence is mounting that traditional clinical laboratory management methods are inferior to new models of …

Beware What Your Lab Competitor is Doing! Read More »

To access this post, you must purchase The Dark Report.

“October 23, 2000 Intelligence: Late Breaking Lab News”

Get ready for the stock market to begin creating multi-millionaires from today’s generation of commercial laboratory executives. Most laboratorians know that Roche sold $430.5 million of its stock holding in Laboratory Corporation of America stock only seven days ago. Lesser known is the fact that LabCorp executives Thomas McMahon and Brad Smith sold a total …

“October 23, 2000 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

AML & Dynacare Next To Try a Public Offering

CEO SUMMARY: There will be plenty of competition for investors’ dollars this fall. American Medical Laboratories and Dynacare will join Specialty Laboratories in the effort to place an initial public offering (IPO). Three laboratory companies coming to market during the same period will certainly demonstrate whether professional investors truly believe that good times lie ahead …

AML & Dynacare Next To Try a Public Offering Read More »

To access this post, you must purchase The Dark Report.

IPO Is Major Strategy For American Med Labs

CEO SUMMARY: Since its acquisition in 1997, American Medical Laboratories’ fast growth was funded by heavy borrowing. Now this Virginia-based lab company needs to raise additional capital so it can restructure its debt and lay a foundation for the next cycle of growth. Its initial public offering of common stock will need to compete with …

IPO Is Major Strategy For American Med Labs Read More »

To access this post, you must purchase The Dark Report.

Dynacare Sets Sights On Raising $89 Million

CEO SUMMARY: Throughout the 1990s, Dynacare weathered the wholesale restructuring of health services in several key Canadian provinces where it operates. In the United States, it sought to build a national base of lab testing even as lab consolidation raged and capitated managed care contracts were common. Having survived in both countries, Dynacare now wants …

Dynacare Sets Sights On Raising $89 Million Read More »

To access this post, you must purchase The Dark Report.

;